We are looking to recruit a skilled, reliable, and enthusiastic Research Associate funded by the Ovarian Cancer Action to investigate the specific role of specific gene mutations (in particular PTEN) in shaping the microenvironment in ovarian high grade serous carcinoma (HGSC). The post will build on previous work from the McNeish lab, which has identified specific macrophage populations that are key to growth and progression of ovarian carcinoma and that may be therapeutic targets.
The postholder will carry out research programmes investigating the role of specific mutations of driving innate and adaptive immune cells changes in HGSC and undertake project management and/or supervision multi-disciplinary teams. In addition, he/she will be expected to submit publications to refereed journals and to help attract external research funding.
You should hold a PhD in Cancer Biology and Cancer Immunology or a closely related discipline. You should have knowledge of cancer immunology and practical experience in a broad range of techniques including flow cytometry and mouse models of cancer. You must be organised, highly self-motivated, have excellent communication and relish working towards milestones.
The Division of Cancer at Imperial College London offers a dynamic and supportive environment for new Research Associates, providing opportunities to engage in cutting-edge research that translates high-quality basic science into clinical applications. The division focuses on stratified and personalized cancer treatment approaches, aiming to transform NHS practices and enhance patient care. New Research Associates will benefit from access to state-of-the-art facilities and the chance to collaborate with leading academics, clinicians, and commercial partners. This vibrant research community is dedicated to advancing cancer prevention, diagnosis, and treatment through multidisciplinary collaborations, fostering an outstanding environment for both academic growth and impactful research contributions.